Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Stockholders??? Equity (Deficit) (Unaudited)

v3.22.2.2
Condensed Statements of Stockholders’ Equity (Deficit) (Unaudited) - USD ($)
$ in Thousands
Series A
Preferred Stock
Series B
Preferred Stock
Series C
Preferred Stock
Series D
Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2020   $ 1 $ 29,758 $ (36,530) $ (6,771)
Balance (in Shares) at Dec. 31, 2020   7,599,716      
Issuance of common stock and warrants, net of fees   19,326 19,326
Issuance of common stock and warrants, net of fees (in Shares)         4,772,500      
Issuance of common stock and preferred stock in connection with conversion of notes   19,222 19,222
Issuance of common stock and preferred stock in connection with conversion of notes (in Shares) 251 1,443 500,756   1,261,277      
Repurchased beneficial conversion feature in connection with conversion of notes payable   (6,647) (6,647)
Issuance of common stock warrants in connection with note exchange agreements   4,918 4,918
Restricted stock awards exchanged for restricted stock units         (800,000)      
Exercise of common stock warrants   180 180
Exercise of common stock warrants (in Shares)         219,199      
Issuance of common stock to consultants   247 247
Issuance of common stock to consultants (in Shares)         64,954      
Issuance of common stock warrants   772 772
Stock-based compensation   8,131 8,131
Stock-based compensation (in Shares)         1,038,095      
Stock option exercise   186 186
Stock option exercise (in Shares)         434,385      
Canceled restricted stock awards (in Shares)         (60,000)      
Reclassification of warrant liabilities   3,566 3,566
Net loss   (31,774) (31,774)
Balance at Sep. 30, 2021   $ 1 79,659 (68,304) 11,356
Balance (in Shares) at Sep. 30, 2021 251 1,443 500,756   14,530,126      
Balance at Jun. 30, 2021   $ 1 76,376 (62,601) 13,776
Balance (in Shares) at Jun. 30, 2021 251 1,443 500,756   14,920,741      
Restricted stock awards exchanged for restricted stock units         $ (800,000)      
Issuance of common stock warrants   772 772
Stock-based compensation   2,329 2,329
Stock option exercise   182 182
Stock option exercise (in Shares)         409,385      
Net loss   (5,703) (5,703)
Balance at Sep. 30, 2021   $ 1 79,659 (68,304) 11,356
Balance (in Shares) at Sep. 30, 2021 251 1,443 500,756   14,530,126      
Balance at Dec. 31, 2021 $ 1 82,677 (73,690) 8,988
Balance (in Shares) at Dec. 31, 2021 251 1,443 500,756   14,530,126      
Delivery of restricted common stock         $ 1     1
Delivery of restricted common stock (in Shares)         1,095,237      
Issuance of common stock and warrants, net of fees   855   855
Issuance of common stock and warrants, net of fees (in Shares)         1,250,000      
Issuance of common stock warrants in connection with SLOC 223 223
Issuance of Series D preferred stock and warrants, net of fees 1,039 1,039
Issuance of Series D preferred stock and warrants, net of fees (in Shares)       1,058        
Issuance of common stock/At-the-market offering, net of offering costs 706 706
Issuance of common stock/At-the-market offering, net of offering costs (in Shares)         1,647,709      
Issuance of common stock warrants in connection with consideration payable 86 86
Stock-based compensation 3,011 3,011
Net loss (12,163) (12,163)
Balance at Sep. 30, 2022 $ 2 88,597 (85,853) 2,746
Balance (in Shares) at Sep. 30, 2022 251 1,443 500,756 1,058 18,523,072      
Balance at Jun. 30, 2022 $ 1 85,489 (82,737) 2,753
Balance (in Shares) at Jun. 30, 2022 251 1,443 500,756   14,614,627      
Delivery of restricted common stock $ 1 1
Delivery of restricted common stock (in Shares)         1,061,905      
Issuance of common stock and warrants, net of fees 855   855
Issuance of common stock and warrants, net of fees (in Shares)         1,250,000      
Issuance of Series D preferred stock and warrants, net of fees 1,039 1,039
Issuance of Series D preferred stock and warrants, net of fees (in Shares)       1,058        
Issuance of common stock/At-the-market offering, net of offering costs 648 648
Issuance of common stock/At-the-market offering, net of offering costs (in Shares)         1,596,540      
Issuance of common stock warrants in connection with consideration payable           86   86
Stock-based compensation   480   480
Net loss (3,116) (3,116)
Balance at Sep. 30, 2022 $ 2 $ 88,597 $ (85,853) $ 2,746
Balance (in Shares) at Sep. 30, 2022 251 1,443 500,756 1,058 18,523,072